NuRx Pharmaceuticals, Inc.
18 Technology Drive
Suite 130
Irvine
California
92618
United States
Tel: 949-336-7111
13 articles about NuRx Pharmaceuticals, Inc.
-
TherapeuticsMD and Nurx Expand Access to ANNOVERA®
7/15/2020
Largest online practice for women’s health now offers the first FDA-approved long-lasting birth control method that does not require a medical procedure
-
Nurx Honors World Contraception Day by Donating Birth Control to Women in Need
9/26/2019
Nurx, the health tech company focused on sensitive health needs and the leading online provider for contraception, today announced a partnership with Power to Decide, the campaign to prevent unplanned pregnancy.
-
Nurx Secures $52 Million to Expand Access to Sensitive Health Needs
8/15/2019
Nurx, the health tech company providing convenient and affordable care for sensitive health needs, today announced it has raised an additional $52 million in funding.
-
Nurx Introduces Convenient & Private STI Home Test Kits
7/10/2019
Nurx, the health tech company addressing sensitive health needs with convenient and affordable solutions today introduced STI Home Test Kits.
-
Nurx Launches First-Ever End-to-End Telehealth HIV Prevention Service Line
8/16/2018
Nurx offers at-home lab testing to expand access to PrEP and combat escalating HIV rates
-
Nurx Launches In Georgia, Offering Home Delivery Of Affordable Birth Control And HIV Prevention
8/6/2018
Telemedicine Platform Expands Access to Prescription Birth Control and PrEP for HIV Prevention To Combat Georgia's Unintended Pregnancy Rate and HIV Epidemic
-
Nurx Launches In Wisconsin, Offering Home Delivery Of Affordable Birth Control And HIV Prevention
8/1/2018
Telemedicine Platform Expands Access to Prescription Birth Control and PrEP for HIV Prevention To Combat Wisconsin's Unintended Pregnancy Rate and Increasing New HIV Cases
-
QuantRx Biomedical Corporation to Acquire NuRx Pharmaceuticals, Inc.
1/29/2010
-
QuantRx Biomedical Corporation Forms Joint Venture with NuRx Pharmaceuticals, Inc. for the Global Launch of Innovative Point-of-Care Products
7/31/2009
-
NuRx Pharmaceuticals, Inc. Announces Change of Ticker Symbol to NUXP, Reverse Stock Split Now in Effect
5/13/2008
-
Rexinoid Developed by NuRx Pharmaceuticals, Inc. Shows Promise in Prevention, Treatment of Lung, Breast Cancer
3/25/2008
-
NuRx Pharmaceuticals, Inc. Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
3/24/2008
-
Quest Group International, Inc. Changes Its Name to NuRx Pharmaceuticals, Inc.
10/30/2007